Síncope

Ganzeboom, 2006, Lifetime cumulative incidence of syncope in the global population: a study of 549 Dutch subjects aged 35–60 years, J Cardiovasc Electrophysiol, 17, 1172, 10.1111/j.1540-8167.2006.00595.x Ungar, 2010, Early and late outcome of treated patients referred for syncope to emergency department. The EGSYS 2 follow-up study, Eur Hert J, 31, 2021, 10.1093/eurheartj/ehq017 Moya, 2009, Guidelines for the diagnosis and management of syncope (version 2009), Eur Heart J, 30, 2631, 10.1093/eurheartj/ehp298 Hoefnagels, 1991, Transient loss of consciousness: the value of the history for distinguishing seizure from syncope, J Neurol, 238, 39, 10.1007/BF00319709 Brignole, 2012, New concepts in the assessment of syncope, JACC, 59, 1583, 10.1016/j.jacc.2011.11.056 Van Dijk, 2008, Is there any point to vasovagal syncope?, Clin Auton Res, 18, 167, 10.1007/s10286-008-0484-x 1996, J Neurol Sci, 144, 218, 10.1016/S0022-510X(96)00206-7 Wieling, 2007, Initial orthostatic hypotension: review of a forgotten condition, Clin Sci (Lond), 112, 157, 10.1042/CS20060091 Gibbons, 2006, Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance, Neurology, 67, 28, 10.1212/01.wnl.0000223828.28215.0b Grubb, 1997, The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt table testing, Pacing Clin Electrophysiol, 20, 2205, 10.1111/j.1540-8159.1997.tb04238.x Leitch, 1992, Syncope associated with supraventricular tachycardia: an expression of tachycardia or vasomotor response?, Circulation, 85, 1064, 10.1161/01.CIR.85.3.1064 Morillo, 1995, Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol, Am Heart J, 129, 901, 10.1016/0002-8703(95)90110-8 Bartoletti, 2000, The Italian Protocol: a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope, Europace, 2, 339, 10.1053/eupc.2000.0125 Bass, 1990, The duration of Holter monitoring in patients with syncope: is 24 h enough?, Arch Intern Med, 150, 1073, 10.1001/archinte.1990.00390170103022 Linzer, 1990, Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope, Am J Cardiol, 66, 214, 10.1016/0002-9149(90)90591-N Farwell, 2006, The clinical impact of implantable loop recorders in patients with syncope, Eur Heart J, 27, 351, 10.1093/eurheartj/ehi602 Olshansky, 1999, Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. The ESVEM Investigators, Am Heart J, 137, 878, 10.1016/S0002-8703(99)70412-6 Mittal, 2001, Significance of inducible ventricular fibrillation in patients with coronary artery disease and unexplained syncope, J Am Coll Cardiol, 38, 371, 10.1016/S0735-1097(01)01379-1 Krediet, 2002, Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing, Circulation, 106, 1684, 10.1161/01.CIR.0000030939.12646.8F Van Dijk, 2006, Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial), J Am Coll Cardiol, 48, 1652, 10.1016/j.jacc.2006.06.059 Reybrouck, 2002, Longterm follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope, Pacing Clin Electrophysiol, 25, 1441, 10.1046/j.1460-9592.2002.01441.x Moya, 1995, Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo, J Am Coll Cardiol, 25, 65, 10.1016/0735-1097(94)00336-O Ward, 1998, Midodrine: a role in the management of neurocardiogenic syncope, Heart, 79, 45, 10.1136/hrt.79.1.45 Salim, 2005, Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a doublé blind, placebo-controlled, randomized trial, J Am Coll Cardiol, 45, 484, 10.1016/j.jacc.2004.11.033 Sheldon, 2006, Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope, Circulation, 113, 1164, 10.1161/CIRCULATIONAHA.105.535161 Di Girolamo, 1999, Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study, J Am Coll Cardiol, 33, 1227, 10.1016/S0735-1097(98)00694-9 Claydon, 2004, Salt supplementation improves orthostatic cerebral and peripheral vascular control in patients with syncope, Hypertension, 43, 809, 10.1161/01.HYP.0000122269.05049.e7 Schroeder, 2002, Water drinking acutely improves orthostatic tolerance in healthy subjects, Circulation, 106, 2806, 10.1161/01.CIR.0000038921.64575.D0 Wright, 1998, A double-blind, doseresponse study of midodrine in neurogenic orthostatic hypotension, Neurology, 51, 120, 10.1212/WNL.51.1.120 Ten Harkel, 1992, Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisones, J Intern Med, 232, 139, 10.1111/j.1365-2796.1992.tb00563.x